← Back to Clinical Trials
Recruiting NCT07561164

NCT07561164 Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07561164
Status Recruiting
Phase
Sponsor Hvidovre University Hospital
Condition Hip Fracture Surgery
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2026-05-11
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
HIP-ME-UP mobility intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2026-05-11 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This clinical study examines whether a co-designed mobility intervention can be delivered in routine hospital care after hip fracture surgery. Hip fracture is a common and serious condition among older adults and is associated with loss of independence, complications, and increased mortality. During hospitalization, many patients remain inactive, even though early and frequent mobility is considered important for recovery. The HIP-ME-UP intervention was developed in collaboration with healthcare professionals, patients, caregivers, and hospital management. It aims to support early mobilization, independence in basic mobility activities such as getting in and out of bed and increased physical activity during hospitalization. The study will investigate whether the intervention is feasible to deliver in routine clinical practice, whether it is delivered as intended, and whether it is acceptable to patients and healthcare professionals. Participants admitted after a hip fracture surgery will receive the intervention during hospitalization. Researchers will collect information on recruitment, retention, fidelity, acceptability, and mobility-related outcomes. Approximately 25 participants will be included. The results will help determine whether a larger effectiveness study should be conducted.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 60 years. * Admitted to one of the two acute orthopedic wards at Copenhagen University Hospital Hvidovre (CUHH) following hip fracture surgery. * Pre-fracture Cumulated Ambulation Score (CAS) (by recall) ≥ 3 points, indicating independence or assisted independence in basic mobility activities such as bed transfer, chair transfer, and indoor walking. * Participants may be included if they are able to provide informed consent independently or if informed consent is obtained from a legally authorized proxy (e.g., caregiver or close relative) in cases of cognitive impairment. This applies to both Danish- and non-Danish speaking patients. Non-Danish speakers may be included with support from translated study materials and assistance from relatives or interpreters, where appropriate. * Inclusion the latest on postoperative day three. Exclusion Criteria: * Non-ambulatory before the fracture, e.g. permanently bedbound or wheelchair-dependent. * Terminal illness with limited expected survival. * Post-operative weight-bearing restrictions precluding mobility activities. * Multiple fractures or suspected pathological fractures (e.g. related to malignancy). * Clinically unstable or presenting conditions in which early mobilization is contraindicated. * Patients who previously participated in HIP-ME-UP Study 4, ensuring that recipients in Study 6 have not been prior HIP-ME-UP study participants or patient partners.

Contact & Investigator

Central Contact

Sofie T Lindholm, MHSc

✉ sofie.tscherning.lindholm.01@regionh.dk

📞 +45 38622230

Principal Investigator

Maria S Hansen, PhD

STUDY DIRECTOR

Copenhagen University Hospital, Hvidovre

Frequently Asked Questions

Who can join the NCT07561164 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Hip Fracture Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07561164 currently recruiting?

Yes, NCT07561164 is actively recruiting participants. Contact the research team at sofie.tscherning.lindholm.01@regionh.dk for enrollment information.

Where is the NCT07561164 trial being conducted?

This trial is being conducted at Hvidovre, Denmark.

Who is sponsoring the NCT07561164 clinical trial?

NCT07561164 is sponsored by Hvidovre University Hospital. The principal investigator is Maria S Hansen, PhD at Copenhagen University Hospital, Hvidovre. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology